Skip to main content

NAD+, MOTS-C & SS-31 Energy Peptides in Southlake

By Dr. Haritha Mikkilineni Updated July 18, 2026 Editorial policy
A woman stands in a sunlit field with her arms outstretched, smiling with her eyes closed.

NAD+, MOTS-C and SS-31 Energy Peptide FAQs

How quickly will I feel results from NAD+, MOTS-C, or SS-31?

The timeline varies depending on which peptide you use and your individual physiology. With NAD+ therapy, many patients notice an energy boost within hours to days of the first infusion, with mental clarity often improving within 1 to 3 days; benefits build over 2 to 4 weeks, optimal results typically arrive around 4 to 8 weeks of consistent therapy, and some benefits persist after treatment ends. With MOTS-C, metabolic improvements often appear in 1 to 2 weeks, energy enhancement in 2 to 4 weeks, exercise performance gains in 3 to 6 weeks, body composition changes in 6 to 12 weeks, and maximum benefits by 8 to 12 weeks. With SS-31, reduced oxidative stress is often reported in 1 to 2 weeks, energy improvements in 2 to 4 weeks, exercise capacity gains in 3 to 6 weeks, cardiovascular benefits in 4 to 8 weeks, and comprehensive optimization by 8 to 12 or more weeks. Most patients at Medrein notice some improvement within the first 1 to 2 weeks, with benefits continuing to build throughout treatment. Results may vary.

Are these energy peptides safe?

As a board-certified ER physician, Dr. Mikki prioritizes patient safety, and all three energy peptides have strong safety profiles when properly prescribed and monitored. NAD+ is a molecule naturally present in every cell and is generally very safe and well tolerated, with extensive research behind it; the main effects some patients notice are temporary flushing during an IV infusion or nausea if it's infused too quickly, both easily managed with proper administration. MOTS-C has shown an excellent safety profile in studies, is naturally occurring in the body, and is well tolerated, with minimal side effects and no significant adverse effects reported in clinical use. SS-31 has undergone extensive safety testing in clinical trials, is well tolerated in research studies, and works protectively rather than as a stimulant, with a good long-term safety profile and minimal side effects. Every patient completes medical screening before starting, and these peptides are not recommended during pregnancy or breastfeeding; Dr. Mikki monitors individual responses and adjusts protocols as needed to keep treatment safe.

How much do NAD+, MOTS-C, and SS-31 therapies cost?

The investment depends on which peptides you choose, your dosing needs, and treatment duration. NAD+ IV infusions typically carry a higher cost per session, with pricing based on dosage (such as 250mg or 500mg) and package pricing available for multiple sessions; subcutaneous NAD+ is generally a more affordable option. MOTS-C is a mid-range investment, with cost depending on dosing and frequency; it's typically dosed 2 to 3 times weekly over treatment cycles of 8 to 12 weeks. SS-31 is a premium peptide therapy that reflects more sophisticated research and development, typically dosed 3 to 5 times weekly, with the investment reflecting its mitochondrial benefits. Combining peptides is available with customized package pricing, and many protocols are HSA/FSA eligible. Pricing is discussed transparently during your consultation, so contact Medrein for current pricing on individual peptides or combination protocols.

Can I combine energy peptides with other treatments?

Yes. Dr. Mikki often combines NAD+, MOTS-C, and SS-31 with complementary therapies, building a customized protocol around your goals. That can include other peptide therapies such as CJC-1295/Ipamorelin for growth hormone optimization or TB-500/BPC-157 for healing and recovery, layered into a comprehensive peptide stack. It can also include lifestyle optimization, such as targeted exercise programming, anti-inflammatory nutrition, sleep optimization, and stress management, alongside IV nutrient therapy for vitamin and mineral optimization, antioxidant support, methylation support, and mitochondrial cofactors. For some patients, Dr. Mikki adds hormone optimization, metabolic testing, or a broader preventive-medicine evaluation as part of a comprehensive health assessment. Results may vary.

How long should I continue energy peptide therapy?

Treatment duration depends on your goals and which peptides you're using. Short-term intensive protocols run about 4 to 8 weeks and are often used for energy restoration after illness, a metabolic reset, or performance optimization ahead of an event. Medium-term optimization protocols run about 12 to 16 weeks for more comprehensive benefits, such as body composition changes, metabolic improvement, or significant overall health gains. For long-term wellness goals like anti-aging, longevity, or chronic condition management, treatment continues on an ongoing basis with periodic breaks and maintenance dosing. Dr. Mikki typically starts with an initial intensive phase, evaluates your results, and then transitions you to a maintenance protocol if desired, reassessing periodically and adjusting based on your response. Many patients complete intensive cycles several times a year, while others continue long-term with lower maintenance dosing for sustained anti-aging benefits. Results may vary.

nad mots-c peptide therapy energy peptides rha
Dr. Haritha Mikkilineni

About the author

Dr. Haritha Mikkilineni, MD

Founder & Medical Director

Board-certified physician and founder of Medrein Health & Aesthetics in Southlake, and the physician who personally consults with you and performs most treatments herself.

Read full bio →
Share:

Get a physician-set NAD+, MOTS-C and SS-31 protocol

Book a consultation and Dr. Mikki will build a plan around your health history.

Related Articles

Book Now Call

Made by FOMO.ai